Back
New CentoXome

Turning Years Into Days

It takes approx. 7 years to diagnose a patient with a rare disease. With NEW CentoXome®, you can turn those years into days.

Read More

CENTOGENE - Revolutionising Genetic Solutions

Explore how CENTOGENE is revolutionizing genetic solutions for patients worldwide

Know More

Coronavirus Testing With CENTOGENE

Coronavirus Testing With CENTOGENE

Enabling you to get back to normal with our range of SARS-CoV-2 testing solutions for individuals and businesses

Read More

Improved Travel With Coronavirus Testing

The Latest Insights Into COVID-19

Keeping you up to date with the most recent news and scientific developments amid the Coronavirus pandemic

Read More

Our goal: providing precise medical diagnosis of inherited diseases at the earliest possible moment; transforming medical expertise and analytical information into actionable results for physicians, patients, and pharmaceutical partners.

Our commitment: life-long support for our patients and partners - driven by the continuous improvement of our diagnostic quality and therapeutic options for individual patients.

CENTOGENE’S LATEST SCIENTIFIC PUBLICATIONS & WEBINARS

NEW CentoXome – Turning Years Into Days

Throughout the CentoTalk, Maximilian Schmid, M.D., and Jorge Pinto Basto, M.D., will…

Improving Diagnostic Options for Rare Diseases

A diagnostic strategy for rare diseases based on a combination of standard laboratory…

Modifiers of Genetic Disease

Therapeutic strategies for monogenic diseases may be derived from the identification and…

A Novel Genetic Cause for Autoinflammation

Genetic inflammatory disorders are quite rare, particularly those presenting with a…

Globally Rare – Locally Common

Genetic diseases that are generally rare may still have a high prevalence in certain…

One Gene – Two Modes of Inheritance

While most genetic disorders have one clearly defined mode of inheritance, the existence…

Six Novel Gene-Disease Associations

While technology has advanced over the past ten years, more than half of patients with…

Recognition of CENTOGENE's Scientific Expertise

Review articles constitute a unique type of scientific publication, as they summarize,…

A Genetic Cause for Infectious Disease

While infectious diseases are commonly connected to environmental factors, genetic defects…

The Importance of Neuronal Membrane Biology

Nerve cells have a uniquely large surface-to-volume ratio, suggesting a central role for…

Company Newsletter

Keep up to date with the latest scientific insights and rare disease news
with your monthly digital edition of CentoBrief

Subscribe Now

CAMBRIDGE, Mass., USA und ROSTOCK & BERLIN, Deutschland, 24. Juni 2021

  • CENTOGENE baut sein Netzwerk an SARS-CoV-2-Testcentern in deutschen Innenstädten und an...
Read more

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, June 22, 2021 (GLOBE NEWSWIRE)

Highlights strategic priorities to lead data-driven insights creation for rare...

Read more

CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, June 16, 2021 (GLOBE NEWSWIRE)

Further signs of recovery in the core rare disease business

Recorded...

Read more

CAMBRIDGE, Mass., USA und ROSTOCK & BERLIN, Deutschland, 16. Juni 2021

  • CENTOGENE, ein etablierter Anbieter von umfassenden SARS-CoV-2-Testslösungen, eröffnet...
Read more

CAMBRIDGE, Mass., USA und ROSTOCK & BERLIN, Deutschland, 11. Juni 2021

  • Das Planen einer Reise, egal ob privater oder beruflicher Natur, ist im Zuge der...
Read more

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, June 9, 2020 (GLOBE NEWSWIRE) - Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on...

Read more

New leadership team to present vision, strategy, and execution roadmap

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, June 7, 2020 (GLOBE NEWSWIRE) -...

Read more

Observational Study to Advance Genetic Understanding of FTD Being Conducted With Support From Alector

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, June...

Read more

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, June 1, 2020 (GLOBE NEWSWIRE)

  • World leader and trusted partner in rare diseases releases enhanced Whole...
Read more